(Q35821319)

10 August 2017

1 reference

title

Proteins interacting with the 26S proteasome (English)

1 reference

10 August 2017

R Hartmann-Petersen

1

1 reference

10 August 2017

C Gordon

series ordinal

2

1 reference

10 August 2017

publication date

1 July 2004

1 reference

Cellular and Molecular Life Sciences

10 August 2017

published in

1 reference

10 August 2017

volume

61

1 reference

10 August 2017

issue

13

1 reference

10 August 2017

page(s)

1589-1595

1 reference

Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes

10 August 2017

cites work

1 reference

12 December 2020

Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis

1 reference

12 December 2020

Rivaroxaban in patients with a recent acute coronary syndrome

1 reference

12 December 2020

2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Associ

1 reference

12 December 2020

Anticoagulant therapy for percutaneous coronary intervention

1 reference

12 December 2020

Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin,

1 reference

12 December 2020

Bivalirudin started during emergency transport for primary PCI.

1 reference

12 December 2020

Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study

1 reference

12 December 2020

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data.

1 reference

12 December 2020

Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events).

1 reference

12 December 2020

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

1 reference

12 December 2020

Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial

1 reference

12 December 2020

Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials

1 reference

12 December 2020

A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation

1 reference

12 December 2020

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

12 December 2020

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

1 reference

12 December 2020

Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial

1 reference

12 December 2020

Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome

1 reference

12 December 2020

Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients

1 reference

12 December 2020

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

1 reference

12 December 2020

Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis.

1 reference

12 December 2020

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

1 reference

12 December 2020

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

1 reference

12 December 2020

1 reference

12 December 2020

Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

1 reference

12 December 2020

Apixaban with antiplatelet therapy after acute coronary syndrome

1 reference

12 December 2020

Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

1 reference

12 December 2020

Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis

1 reference

12 December 2020

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

1 reference

12 December 2020

Warfarin, aspirin, or both after myocardial infarction

1 reference

12 December 2020

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study

1 reference

12 December 2020

Early versus delayed, provisional eptifibatide in acute coronary syndromes

1 reference

12 December 2020

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

12 December 2020

Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction.

1 reference

12 December 2020

Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial.

1 reference

12 December 2020

Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial.

1 reference

12 December 2020

Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting

1 reference

12 December 2020

Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system

1 reference

12 December 2020

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

1 reference

12 December 2020

Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention

1 reference

12 December 2020

Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry).

1 reference

12 December 2020

Bivalirudin for patients with acute coronary syndromes

1 reference

12 December 2020

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

1 reference

12 December 2020

Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial.

1 reference

12 December 2020

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

1 reference

12 December 2020

Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology

1 reference

12 December 2020

Persistent activation of coagulation mechanism in unstable angina and myocardial infarction

1 reference

12 December 2020

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

1 reference

12 December 2020

Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit

1 reference

12 December 2020

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

12 December 2020

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

12 December 2020

Third universal definition of myocardial infarction

1 reference

12 December 2020

The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties

1 reference

12 December 2020

Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial

1 reference

12 December 2020

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

12 December 2020

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

1 reference

12 December 2020

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

12 December 2020

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.

1 reference

12 December 2020

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

1 reference

12 December 2020

Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial

1 reference

12 December 2020

Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention

1 reference

12 December 2020

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

1 reference

12 December 2020

10.1007/S00018-004-4132-X

Identifiers

DOI

1 reference

10 August 2017

1 reference